In Brief: Benzodiazepines
Executive Summary
Benzodiazepines: Public hearing on abuse potential and controlled substance scheduling criteria for benzodiazepines will be held by FDA Sept. 11-12. The meeting will address whether different benzodiazepines may be distinguishable according to their abuse potential. Carter-Wallace has petitioned for the descheduling of its benzodiazepine Doral (quazepam). The hearing will be held at the Renaissance Hotel in Washington, D.C. beginning at 9 a.m. both days...